Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office
QuintilesIMS
US Army
Boehringer Ingelheim
Fuji
AstraZeneca
Mallinckrodt
Citi

Generated: April 25, 2018

DrugPatentWatch Database Preview

CEFOTAXIME Drug Profile

« Back to Dashboard

When do Cefotaxime patents expire, and what generic alternatives are available?

Cefotaxime is a drug marketed by Fresenius Kabi Usa, Hikma, Wockhardt, B Braun, Aurobindo Pharma, Aurobindo Pharma Ltd, Cephazone Pharma, Hospira Inc, and Lupin. and is included in fourteen NDAs.

The generic ingredient in CEFOTAXIME is cefotaxime sodium. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotaxime sodium profile page.
Drug patent expirations by year for CEFOTAXIME
Pharmacology for CEFOTAXIME
Medical Subject Heading (MeSH) Categories for CEFOTAXIME
Synonyms for CEFOTAXIME
(+)-Cefotaxime sodium salt
(6R-(6-a,7-b(Z)))-3-((Acetyloxy) methyl)-7- (((2-amino-4-thiazolyl) (methoxyimio) acetyl) amino)-8- oxo-5-thia-1- azabicyclo (4,2,0) oct-2-ene-2-carboxylic acid, sodium salt
(6R-(6-a,7-b(Z)))-3-((Acetyloxy) methyl)-7-(((2-amino-4-thiazolyl) (methoxyimio) acetyl) amino)-8-oxo-5-thia-1-azabicyclo (4,2,0) oct-2-ene-2-carboxylic acid, sodium salt
(6R,7R,Z)-3-(ACETOXYMETHYL)-7-(2-(2-AMINOTHIAZOL-4-YL)-2-(METHOXYIMINO)-ACETAMIDO)-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID SODIUM
(6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt
258J72S7TZ
3-[(Acetyloxy)methyl]-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amin]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate sodium salt
478250-23-6
5-Thia-1-azabicyclo(4,2,0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6-alpha,7-beta(Z))), sodium salt
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, monosodium salt, (6R-(6alpha,7beta(Z)))-
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-(acetyloxy)methyl-7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo, monosodium salt, [6R-[6alpha,7 beta (Z)]]-
63527-52-6 (acid)
63527-52-6 (Parent)
64485-93-4
7-[2-(2-AMINO-4-THIAZOLYL)GLYOXYLAMIDO]-3-(HYDROXYMETHYL)-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE 7(2)-(Z)-(O-METHYLOXIME) ACETATE, NA
A834407
AB0073048
AB03027
AB1009356
AC-23966
AK249539
AK326216
AKOS003274997
AKOS015951272
AKOS015961149
AKOS027282526
AKOS027327590
AmbscH-042283
AN-38760
AZZMGZXNTDTSME-JUZDKLSSSA-M
BIC0111
C 7912
C08113
C16H16N5NaO7S2
C16H16N5O7S2.Na
CAS-64485-93-4
CCG-220139
CCG-221582
CCG-38937
Cefadroxil, Antibiotic for Culture Media Use Only
CEFOPERAZONE SODIUM SALT U.S.P.
Cefotax
Cefotaxim sodium
Cefotaxim sodium salt
Cefotaxime (sodium salt)
Cefotaxime and dextrose 2.4% in plastic container
Cefotaxime and dextrose 3.9% in plastic container
Cefotaxime for peak identification, European Pharmacopoeia (EP) Reference Standard
CEFOTAXIME NA-SALT
CEFOTAXIME SODIUM
Cefotaxime sodium (JP17/USP)
Cefotaxime sodium [USAN:JAN]
Cefotaxime sodium [USAN:USP:JAN]
CEFOTAXIME SODIUM SALT
Cefotaxime sodium salt (syn-isomer)
Cefotaxime sodium salt, plant cell culture tested, BioReagent, powder
Cefotaxime sodium salt, potency: 916-964 mug per mg
Cefotaxime sodium, European Pharmacopoeia (EP) Reference Standard
Cefotaxime sodium, United States Pharmacopeia (USP) Reference Standard
Cefotaximesodium
CHEBI:3498
CHEMBL1010
CHEMBL3561962
Claforan
Claforan (TN)
CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Claforan sodium
CPD001551784
D00919
DR002957
DSSTox_CID_26991
DSSTox_GSID_46991
DSSTox_RID_82039
DTXSID4046991
EINECS 264-915-9
EN300-122614
EU-0100278
FT-0603036
HE372323
HMS1568K20
HMS1920K09
HMS2091A12
HMS2095K20
HMS2233J21
HMS3259D08
HMS3260H18
HMS3373G07
HMS502G09
HR 756
HR-756
I06-1759
J10142
K035
KS-00004E9I
KS-1416
LP00278
LS-149921
MCULE-9988072641
MFCD00079073
MFCD19705570
MLS000028559
MLS001077352
MLS001333684
MLS002222330
MolPort-003-928-040
MolPort-016-582-515
MolPort-027-714-060
NC00704
NCGC00017128-01
NCGC00093734-01
NCGC00093734-02
NCGC00260963-01
NE54506
Opera_ID_1945
Prestwick_823
Pretor
Q-200807
Ralopar
RU 24756
s4517
SAM002643511
SCHEMBL41092
SCHEMBL537163
SCHEMBL9491367
SMR000058812
SMR000653480
SMR001307269
Sodium (6R-(6alpha,7beta(Z)))-3-(acetoxymethyl)-7-((2-aminothiazol-4-yl)(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
SODIUM (6R,7R)-3-(ACETOXYMETHYL)-7-((E)-2-(2-AMINOTHIAZOL-4-YL)-2-(METHOXYIMINO)ACETAMIDO)-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE
Sodium (6R,7R)-3-(acetoxymethyl)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-3-(acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Sodium (6R,7R)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate 7(sup 2)-(Z)-(O-methyloxime), acetate (ester)
Sodium (6R,7R)-7-[2-(2-amino-4-thiazolyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 7[2]-(Z)-(O-methyloxime), acetate (ester)
SODIUM (6S,7S)-3-[(ACETYLOXY)METHYL]-7-[(2Z)-2-(2-AMINO-1,3-THIAZOL-4-YL)-2-(METHOXYIMINO)ACETAMIDO]-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE
Sodium 3-(acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium 3-(acetoxymethyl)-7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3,4-didehydrocepham-4-carboxylate
sodium 3-(acetyloxymethyl)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium 3-(acetyloxymethyl)-7-[[2-(2-azanyl-1,3-thiazol-4-yl)-2-methoxyimino-ethanoyl]amino]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium 3-[(acetyloxy)methyl]-7-[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium 3-[(acetyloxy)methyl]-7-{[(2-amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-
Sodium 7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)cephalosporanate
Sodium cefotaxime
sodium;(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
SPECTRUM1500165
TL8004572
Tolycar
Tolycor
Tox21_110791
Tox21_500278
UNII-258J72S7TZ
Zariviz

US Patents and Regulatory Information for CEFOTAXIME

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin CEFOTAXIME SODIUM cefotaxime sodium INJECTABLE;INJECTION 065124-001 Sep 24, 2003 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wockhardt CEFOTAXIME SODIUM cefotaxime sodium INJECTABLE;INJECTION 065197-003 Jun 20, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa CEFOTAXIME cefotaxime sodium INJECTABLE;INJECTION 064200-002 Mar 24, 2000 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira Inc CEFOTAXIME SODIUM cefotaxime sodium INJECTABLE;INJECTION 065290-002 Aug 11, 2006 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Daiichi Sankyo
McKinsey
Cipla
Federal Trade Commission
Chinese Patent Office
Dow
Merck
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.